UCSF

ZINC00001655

Substance Information

In ZINC since Heavy atoms Benign functionality
September 27th, 2005 19 Yes

Other Names:

2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid

6385-02-0; C02996; Meclofenamate sodium; Meclofenamic acid sodium salt

6385-02-0; D08162; Meclofenamate sodium; Meclomen (TN)

6385-02-0; Meclofenamic acid sodium salt monohydrate; Prestwick_829

644-62-2; C07117; Meclofenamate; Meclofenamic acid

644-62-2; D02341; Meclofenamic acid (USAN/INN)

Acide meclofenamique [INN-French]

Acide meclofenamique [INN-French];Acido meclofenamico [INN-Spanish];Acidum meclofenamicum [INN-Latin];Meclofenamate;Meclomen (free acid);Meclophenamic acid

acide meclofenamique; acido meclofenamico; acidum meclofenamicum; meclofenamic acid

Acido meclofenamico [INN-Spanish]

Acidum meclofenamicum [INN-Latin]

Anthranilic acid, N-(2,6-dichloro-m-tolyl)-, monosodium salt; Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium salt; Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium salt, monohydrate; C14H10Cl2NO2.Na; CI 583; EINECS 228-

Arquel

BRD-K50398167-236-02-9

CI-583

CI-583; INF 4668; Meclofenamate; Meclofenamic acid; N-(2,6-dichloro-3-methylphenyl)anthranilic acid; N-(2,6-dichloro-m-tolyl)anthranilic acid; N-(3-methyl-2,6-dichlorophenyl)anthranilic acid

CI-583; INF-4668; CL-583; CL-583.NA SALT

CI-853

CL-583

CL-583.NA SALT

CPD000058785; Meclomen; SAM002548942

DNC000919

FDA)

INF-4668

INN

Lenidolor

Meclodium

Meclodol

Meclofenamate

Meclofenamate (sodium salt)

Meclofenamate Sodium

Meclofenamate Sodium (FDA

Meclofenamic acid

Meclofenamic Acid (BAN

Meclofenamic acid sodium salt

Meclofenamic acid sodium salt monohydrate

meclofenamic acid(1-)

Meclomen

Meclomen (free acid)

Meclophenamic acid

MFCD00072053

MFCD00077376

N/A

sodium 2-[(2,6-dichloro-3-methylphenyl)amino]benzoate

sodium meclofenamate

Sodium Meclofenamate Monohydrate

USAN

USAN)

USAN); Meclofenamate sodium (FDA

USAN); Meclofenamate Sodium (USAN

USP

USP)

USP); Meclofenamic Acid (BAN

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 5.63 8.75 -48.65 1 3 -1 52 295.145 3
Hi High (pH 8-9.5) 2.68 5.29 -5.41 0 1 0 12 145.205 0

Vendor Notes

Note Type Comments Provided By
MP 290 - 292 Enamine Building Blocks
MP 290...292 Enamine Building Blocks
ALOGPS_SOLUBILITY 3.66e-03 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
UniProt Database Links ANO2_HUMAN; ANO2_MOUSE; PGH2_MOUSE ChEBI
Therapy antiinflammatory, antipyretic SMDC Iconix
Target COX Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Enamine; NCC_SUPPLIER_STRUCTURE_ID : 207702802; 1 Sodium NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Enamine; SUPPLIER_STRUCTURE_ID: 207702802; SALT: 1 Sodium NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
FABPI-3-E Fatty Acid Binding Protein Intestinal (cluster #3 Of 3), Eukaryotic Eukaryotes 8900 0.37 Binding ≤ 10μM
FABPL-2-E Fatty Acid-binding Protein, Liver (cluster #2 Of 4), Eukaryotic Eukaryotes 379 0.47 Binding ≤ 10μM
PGH1-1-E Cyclooxygenase-1 (cluster #1 Of 6), Eukaryotic Eukaryotes 100 0.52 Binding ≤ 10μM
PGH1-1-E Cyclooxygenase-1 (cluster #1 Of 6), Eukaryotic Eukaryotes 100 0.52 Binding ≤ 10μM
PGH2-3-E Cyclooxygenase-2 (cluster #3 Of 8), Eukaryotic Eukaryotes 100 0.52 Binding ≤ 10μM
PGH2-3-E Cyclooxygenase-2 (cluster #3 Of 8), Eukaryotic Eukaryotes 400 0.47 Binding ≤ 10μM
Z80419-1-O RBL-1 (Basophilic Leukemia Cells) (cluster #1 Of 2), Other Other 100 0.52 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
PGH1_RAT Q63921 Cyclooxygenase-1, Rat 100 0.52 Binding ≤ 1μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 50 0.54 Binding ≤ 1μM
PGH2_MOUSE Q05769 Cyclooxygenase-2, Mouse 200 0.49 Binding ≤ 1μM
PGH2_RAT P35355 Cyclooxygenase-2, Rat 100 0.52 Binding ≤ 1μM
PGH2_HUMAN P35354 Cyclooxygenase-2, Human 40 0.55 Binding ≤ 1μM
FABPL_RAT P02692 Fatty Acid-binding Protein, Liver, Rat 256 0.49 Binding ≤ 1μM
PGH1_RAT Q63921 Cyclooxygenase-1, Rat 100 0.52 Binding ≤ 10μM
PGH1_HUMAN P23219 Cyclooxygenase-1, Human 50 0.54 Binding ≤ 10μM
PGH2_MOUSE Q05769 Cyclooxygenase-2, Mouse 200 0.49 Binding ≤ 10μM
PGH2_RAT P35355 Cyclooxygenase-2, Rat 100 0.52 Binding ≤ 10μM
PGH2_HUMAN P35354 Cyclooxygenase-2, Human 40 0.55 Binding ≤ 10μM
FABPI_HUMAN P12104 Fatty Acid Binding Protein Intestinal, Human 8900 0.37 Binding ≤ 10μM
FABPL_RAT P02692 Fatty Acid-binding Protein, Liver, Rat 256 0.49 Binding ≤ 10μM
Z80419 Z80419 RBL-1 (Basophilic Leukemia Cells) 100 0.52 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
COX reactions
Nicotinamide salvaging
PPARA activates gene expression
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alp
Synthesis of 15-eicosatetraenoic acid derivatives
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.